Market Overview:
The global oral thin film drugs market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in oral thin film drug delivery systems. Based on type, the global oral thin film drugs market is segmented into sublingual films and fully dissolving dental/buccal films. The sublingual films segment is expected to account for the majority share of the global oral thin film drugs market in 2018 owing to their ease of use and high patient compliance rates. Based on application, the global oral thin film drugs market is segmented into schizophrenia, migraine, opioid dependence, nausea & vomiting, and others (cardiovascular disorders, respiratory disorders). The schizophrenia segment accounted for the largest share of the global oral thin Film Drugs Market in 2017 due to increasing incidence rates of this disorder across all regions worldwide. However, with increasing awareness about various treatment options available for different types of chronic diseases such as migraine and opioid dependence among patients globally coupled with technological advancements that are making these treatments more accessible through orally disintegrating tablets (ODTs), buccal patches/strips etc.
Product Definition:
Oral thin film drugs are a newer type of drug delivery system that is used to administer medications. These films are placed on the tongue and dissolve, allowing the medication to be absorbed directly into the bloodstream. This type of drug delivery system is important because it allows for rapid absorption of medications and improved bioavailability.
Sublingual Film:
Sublingual films are thin, adhesive sheets that are placed under the tongue for absorbing drugs through the tissues into the bloodstream. They work by allowing drug molecules to bind to protein receptors present on cells. The process is usually painless and requires no special training; it just takes a little practice.
The market for sublingual films has been growing at a steady pace over the past few years due to increasing demand in various applications such as treatment of diabetes, obesity.
Fully Dissolving Dental/Buccal Film:
Fully dissolving dental/buccal film is a type of drug delivery system that delivers drugs to the site of action without being absorbed into the body. The fully dissolving films are available in different forms such as tablets, lozenges, and gels. These products have gained wide acceptance due to their quick onset of action and ease of use.
Application Insights:
The others segment held the largest share of the global market in 2017. This includes diabetes, HIV, and cancer treatment. The growing prevalence of these diseases is expected to drive demand for ODT drugs over the forecast period. In addition, this segment is anticipated to witness lucrative growth owing to increasing incidences of drug-resistant forms of cancer and other chronic diseases that require long-term medication management such as diabetes and HIV infection.
The schizophrenia application segment is also estimated to grow at a considerable rate during the forecast period due to high unmet medical needs in this population along with increasing adoption rates for antipsychotic oral thin film drugs globally which are currently limited only by supply side factors such as manufacturing capabilities and distribution channels.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare infrastructure, high disposable income, and awareness regarding new treatment options are some factors responsible for its large share. Moreover, a growing number of approvals by regulatory bodies is expected to fuel the regional product demand during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising geriatric population and prevalence of mental disorders coupled with improving economic conditions in emerging countries such as China and India. Furthermore, increasing investments by major pharmaceutical companies for R&D activities will support regional growth during the forecast period. For instance, Sun Pharma & WOCKHARDT invested around USD X million from 2014-2016 on research activities pertaining to oral thin films in India which supports its further development as an oral therapeutic option across this region (excluding Japan).
Growth Factors:
- Increasing prevalence of oral diseases and disorders: The global prevalence of oral diseases and disorders is increasing rapidly. This is mainly due to the changing lifestyles and dietary habits of people across the world. Oral thin film drugs offer an effective and convenient treatment for various oral diseases and disorders, which is expected to drive the growth of this market in the coming years.
- Growing demand for minimally invasive treatments: Oral thin film drugs are minimally invasive treatments, which makes them more popular among patients as well as healthcare professionals. The growing demand for minimally invasive treatments is expected to boost the growth of this market in the near future.
- Rising awareness about oral health: There has been a significant increase in awareness about oral health among people across the world in recent years. This has led to an increase in demand for better treatment options for various dental problems, including tooth decay, gum disease, etc., Oral thin film drugs offer a number of benefits over traditional methods such as pills or injections, which is likely to fuel their growth in the coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Thin Film Drugs Market Research Report
By Type
Sublingual Film, Fully Dissolving Dental/Buccal Film
By Application
Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others
By Companies
Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma, Wolters Kluwer, Sumitomo Dainippon Pharma Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Oral Thin Film Drugs Market Report Segments:
The global Oral Thin Film Drugs market is segmented on the basis of:
Types
Sublingual Film, Fully Dissolving Dental/Buccal Film
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sumitomo Dainippon Pharma Co., Ltd.
- Pfizer
- Novartis AG
- ZIM Laboratories Limited
- Indivior Plc.
- Allergan Plc.
- IntelGenx Corp
- NAL Pharma
- Wolters Kluwer
- Sumitomo Dainippon Pharma Co., Ltd.
Highlights of The Oral Thin Film Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sublingual Film
- Fully Dissolving Dental/Buccal Film
- By Application:
- Schizophrenia
- Migraine
- Opioid Dependence
- Nausea & Vomiting
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Thin Film Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral thin film drugs are medications that are taken by mouth. They are often prescribed to treat conditions such as cancer, HIV, and arthritis.
Some of the major players in the oral thin film drugs market are Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma, Wolters Kluwer, Sumitomo Dainippon Pharma Co., Ltd..
The oral thin film drugs market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Thin Film Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Thin Film Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Thin Film Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Thin Film Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Thin Film Drugs Market Size & Forecast, 2020-2028
4.5.1 Oral Thin Film Drugs Market Size and Y-o-Y Growth
4.5.2 Oral Thin Film Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Sublingual Film
5.2.2 Fully Dissolving Dental/Buccal Film
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Schizophrenia
6.2.2 Migraine
6.2.3 Opioid Dependence
6.2.4 Nausea & Vomiting
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Thin Film Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Thin Film Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Sublingual Film
9.6.2 Fully Dissolving Dental/Buccal Film
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Schizophrenia
9.10.2 Migraine
9.10.3 Opioid Dependence
9.10.4 Nausea & Vomiting
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Sublingual Film
10.6.2 Fully Dissolving Dental/Buccal Film
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Schizophrenia
10.10.2 Migraine
10.10.3 Opioid Dependence
10.10.4 Nausea & Vomiting
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Sublingual Film
11.6.2 Fully Dissolving Dental/Buccal Film
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Schizophrenia
11.10.2 Migraine
11.10.3 Opioid Dependence
11.10.4 Nausea & Vomiting
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Sublingual Film
12.6.2 Fully Dissolving Dental/Buccal Film
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Schizophrenia
12.10.2 Migraine
12.10.3 Opioid Dependence
12.10.4 Nausea & Vomiting
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Sublingual Film
13.6.2 Fully Dissolving Dental/Buccal Film
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Schizophrenia
13.10.2 Migraine
13.10.3 Opioid Dependence
13.10.4 Nausea & Vomiting
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Thin Film Drugs Market: Competitive Dashboard
14.2 Global Oral Thin Film Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sumitomo Dainippon Pharma Co., Ltd.
14.3.2 Pfizer
14.3.3 Novartis AG
14.3.4 ZIM Laboratories Limited
14.3.5 Indivior Plc.
14.3.6 Allergan Plc.
14.3.7 IntelGenx Corp
14.3.8 NAL Pharma
14.3.9 Wolters Kluwer
14.3.10 Sumitomo Dainippon Pharma Co., Ltd.
